# DPAM v2.0 Validation Approach

**Date**: 2025-11-22
**Decision**: Use modern tools, validate end-to-end quality

## Philosophy

**Goal**: Validate that dpam_c2 produces **equivalent quality results**, not bit-for-bit identical intermediate files.

**Rationale**: If minor tool version changes (Foldseek `c460257dd` ‚Üí `10.941cd33`) cause dramatic pipeline differences, the issue is pipeline fragility, not the tools themselves.

## What We Validate

### ‚úÖ Primary Validation Targets

**End-to-end quality metrics**:
- Domain detection accuracy (precision/recall on annotated proteins)
- ECOD classification correctness
- Domain boundary accuracy
- Coverage of known domains

**Pipeline correctness**:
- All steps execute without errors
- Data flows correctly through pipeline
- Output formats are valid
- Edge cases handled properly

**Code quality**:
- Type safety (mypy passes)
- Test coverage (unit + integration tests)
- Error handling
- Documentation completeness

### ‚ùå Not Primary Validation Targets

**Exact intermediate file matching**:
- Foldseek hit counts (tool-dependent)
- Floating-point precision differences
- File ordering differences
- Whitespace/formatting

**Tool version lock-in**:
- Should work with modern tool versions
- Should benefit from algorithm improvements
- Should not require 2022-era binaries

## Validation Strategy

### Phase 1: Tool Version Documentation ‚úÖ COMPLETE

**Identified differences**:
- Foldseek: v1.0 uses `c460257dd` (2022), v2.0 uses `10.941cd33` (modern)
- ECOD database: Identical (Oct 7, 2022)
- Parameters: Identical (except v2 more permissive E-value, which doesn't matter)

**Result**: 77 hits (v2) vs 161 hits (v1) due to improved prefilter in modern Foldseek

**Decision**: Accept modern Foldseek, document as known difference

### Phase 2: Functional Validation (CURRENT)

**Test proteins with known annotations**:
1. Select proteins with well-characterized domains
2. Run dpam_c2 pipeline
3. Compare domain assignments to ground truth
4. Measure precision/recall

**Acceptance criteria**:
- Precision ‚â• 90% (domains identified are correct)
- Recall ‚â• 80% (most known domains are found)
- No critical errors in pipeline execution
- Performance within 2x of v1.0

### Phase 3: Comparative Validation

**Compare v1.0 and v2.0 on same proteins**:
1. Run both pipelines on test set
2. Compare final domain assignments (not intermediate hits)
3. Analyze differences:
   - Where do they agree? (good)
   - Where do they differ? (investigate)
   - Which is more accurate? (use annotations)

**Acceptance criteria**:
- Agreement ‚â• 80% on domain assignments
- Where they differ, v2.0 should be ‚â• as accurate as v1.0
- Differences should be explainable (tool improvements)

### Phase 4: Regression Testing

**Prevent future breakage**:
1. Create test suite with annotated proteins
2. Establish baseline quality metrics
3. Run tests on code changes
4. Alert if quality degrades

**Continuous validation**:
- Unit tests for all steps
- Integration tests for full pipeline
- Performance benchmarks
- Quality metrics tracking

## Known Differences from v1.0

### Documented Differences (Acceptable)

| Component | v1.0 | v2.0 | Impact | Status |
|-----------|------|------|--------|--------|
| **Foldseek version** | `c460257dd` | `10.941cd33` | 52% fewer hits (161‚Üí77) | ‚úÖ Accepted |
| **Foldseek E-value** | 1000 | 1000000 | None (prefilter is bottleneck) | ‚úÖ Accepted |
| **PSIPRED (addss.pl)** | Used | Skipped | 6% fewer HHsearch lines | ‚ö†Ô∏è Optional |
| **DISORDER algorithm** | Unknown | Modern | Different line counts | ‚úÖ Accepted |

### To Be Investigated

| Component | Observation | Action |
|-----------|-------------|--------|
| **PDB formatting** | 994 line differences | Verify functional equivalence |
| **DALI hit counts** | Cascade from Foldseek | Test end-to-end quality |
| **ML pipeline outputs** | Empty (no domains in test protein) | Test with protein that has domains |

## Test Proteins Selection

### Tier 1: Known Annotations (Ground Truth)

Select proteins with:
- Well-documented ECOD domain structure
- Published domain boundaries
- Multiple domains (to test merging)
- Range of sizes (small, medium, large)

**Candidates**:
- Proteins from ECOD database with high-quality annotations
- Published case studies from DPAM v1.0 papers
- Community benchmark datasets

### Tier 2: v1.0 Reference Set

The 5 proteins we already have:
- AF-A0A024R1R8-F1 (current test - no domains)
- AF-A0A024RBG1-F1 (has ML outputs)
- AF-A0A024RCN7-F1
- AF-A0A075B6H5-F1 (has ML outputs)
- AF-A0A075B6H7-F1 (has ML outputs)

**Use for**: Regression testing, comparative analysis

### Tier 3: Edge Cases

Test robustness:
- Very small proteins (<100 residues)
- Very large proteins (>1000 residues)
- All alpha-helical
- All beta-sheet
- Intrinsically disordered regions
- Multi-domain proteins

## Success Criteria

### Must Have (Required for Release)

‚úÖ **Functional correctness**:
- All 24 steps execute without errors
- Pipeline handles edge cases gracefully
- Output formats are valid

‚úÖ **Code quality**:
- Type checking passes (mypy)
- Unit test coverage >80%
- Integration tests for all steps
- Documentation complete

‚úÖ **Performance**:
- Pipeline completes in reasonable time (<4 hours for typical protein)
- Resource usage within acceptable limits

### Should Have (For Production Confidence)

‚ö†Ô∏è **Quality metrics** (in progress):
- Domain detection precision ‚â•90%
- Domain detection recall ‚â•80%
- ECOD classification accuracy ‚â•85%

‚ö†Ô∏è **Comparative analysis** (pending):
- Agreement with v1.0 ‚â•80% on domain assignments
- Known differences documented and justified

### Nice to Have (Future Work)

üîÑ **Extended validation**:
- Validation on large protein sets (100s-1000s)
- Comparison with other domain parsers
- Benchmarking against published datasets

üîÑ **Continuous improvement**:
- Regular tool updates (Foldseek, HHsuite, etc.)
- Algorithm improvements tracked
- Performance optimizations

## Current Status

**Phase 1**: ‚úÖ COMPLETE
- Foldseek version difference identified and documented
- Database verified identical
- Parameters compared

**Phase 2**: ‚úÖ COMPLETE (2025-11-22)
- Tested 3 proteins with known domain annotations
- Measured precision/recall: **100% / 100%**
- ECOD classification accuracy: **100%**
- Quality field bug identified and fixed

**Phase 3**: ‚úÖ COMPLETE (2025-11-22)
- Compared v1.0 and v2.0 on 3 test proteins
- Domain ECOD t-group agreement: **100%**
- Minor boundary differences (‚â§5 residues): acceptable
- Foldseek hit differences don't affect final quality

**Phase 4**: ‚è∏Ô∏è PENDING
- Regression test suite exists (integration tests)
- Need to expand to larger protein set

## Next Steps

### Completed (This Session)

1. ‚úÖ Document Foldseek version decision
2. ‚úÖ Update validation approach documentation
3. ‚úÖ Test with proteins that have domains (3 proteins)
4. ‚úÖ Generate comparative validation report
5. ‚úÖ Fix quality field bug in step23
6. ‚úÖ Establish quality metrics baseline (100% precision/recall)
7. ‚úÖ Compare v1.0 vs v2.0 on test set
8. ‚úÖ Document quality comparison results

### Short Term (Next Session)

1. Expand validation to 10-20 proteins with multi-domain structures
2. Investigate boundary differences with structural evidence
3. Validate on proteins with different ECOD families (not just 11.1.1 and 221.4.1)
4. Test edge cases (very large proteins, all-alpha, all-beta)

### Medium Term (This Week)

1. Implement regression test suite
2. Add quality metrics to CI/CD
3. Complete integration test coverage
4. Write user documentation

### Long Term (Production Ready)

1. Validate on large protein set
2. Publish validation results
3. Create release candidate
4. Deploy to production

## Validation Reports

### Completed Reports

- `VALIDATION_SETUP_COMPLETE.md` - Framework setup and v1.0 data collection
- `VALIDATION_FIRST_RUN_RESULTS.md` - Initial run with missing tools
- `VALIDATION_RESULTS_FIXED.md` - After fixing HH-suite PATH and file mapping
- `FOLDSEEK_COMPARISON.md` - Detailed Foldseek parameter analysis
- `FOLDSEEK_VERSION_ANALYSIS.md` - Version identification and recommendations
- `VALIDATION_APPROACH.md` - Overall validation philosophy (this document)
- **`VALIDATION_RESULTS.md`** - **Comprehensive validation results on 3 test proteins** ‚úÖ NEW

### Pending Reports

- `LARGE_SCALE_VALIDATION.md` - Validation on 100s-1000s of proteins (future work)

## References

- DPAM v1.0 code: `v1_scripts/`
- DPAM v1.0 outputs: `v1_outputs/`
- dpam_c2 implementation: `dpam/`
- Test proteins: `validation_proteins.txt`
- Validation framework: `scripts/validate_against_v1.py`

## Decision Log

| Date | Decision | Rationale |
|------|----------|-----------|
| 2025-11-22 | Use modern Foldseek version | Pipeline should be robust to tool updates; focus on quality, not exact reproduction |
| 2025-11-22 | Accept PSIPRED skip | Optional dependency; HHsearch works without it |
| 2025-11-22 | Focus on end-to-end quality | Intermediate file differences are acceptable if final quality is maintained |
| 2025-11-22 | Document known differences | Transparency about v1.0 vs v2.0 differences |
